• 1. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 2. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

• Natural Products and Extracts Plant Extracts Plant based Cyphanthera myosotidea
• Natural Products and Extracts Plant Extracts Plant based Crenidium spinescens
• Natural Products and Extracts Plant Extracts Plant based Anthocercis ilicifolia

Introduction to (±)-Atropine-d3 (N-methyl-d3) and Its Applications in Modern Research

Chemical compounds play a pivotal role in the advancement of pharmaceutical research and development. Among these, (±)-Atropine-d3 (N-methyl-d3), identified by its CAS number 1276197-36-4, stands out as a significant isotope-labeled compound with diverse applications in the field of medicinal chemistry. This compound, characterized by its deuterium-labeled structure, offers unique advantages in analytical and synthetic chemistry, particularly in the study of pharmacokinetics and metabolic pathways.

The CAS number 1276197-36-4 provides a unique identifier for this compound, ensuring precise classification and differentiation in chemical databases and research literature. The presence of deuterium atoms in (±)-Atropine-d3 (N-methyl-d3) enhances its stability and isotopic purity, making it an invaluable tool for researchers aiming to investigate the detailed mechanisms of drug metabolism and interaction with biological targets.

In recent years, the demand for high-purity labeled compounds has surged due to their critical role in nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) analyses. These techniques are indispensable for elucidating the structural properties of complex molecules. The (±)-Atropine-d3 (N-methyl-d3) compound serves as an excellent probe for these analytical methods, providing clear and interpretable spectral data that aid in the characterization of pharmaceutical intermediates and active pharmaceutical ingredients (APIs).

One of the most compelling applications of (±)-Atropine-d3 (N-methyl-d3) is in the field of drug discovery and development. Its labeled structure allows researchers to track the metabolic fate of atropine derivatives, offering insights into how these compounds are processed within living systems. This information is crucial for optimizing drug formulations and predicting potential side effects. The use of deuterium-labeled compounds has revolutionized the way metabolic studies are conducted, providing a non-invasive yet highly accurate method for understanding drug interactions at the molecular level.

Moreover, the CAS number 1276197-36-4 associated with (±)-Atropine-d3 (N-methyl-d3) facilitates seamless integration into existing chemical databases and research platforms. This compatibility ensures that researchers can easily access relevant data, including safety profiles, solubility information, and spectral references, thereby streamlining the research process. The compound's isotopic purity also minimizes background noise in analytical experiments, leading to more reliable and reproducible results.

The significance of (±)-Atropine-d3 (N-methyl-d3) extends beyond academic research. Pharmaceutical companies leveraging advanced labeling technologies are able to develop more effective drugs with improved safety profiles. The ability to monitor drug metabolism in real-time using labeled compounds like this one has led to significant breakthroughs in personalized medicine. By understanding how individual patients metabolize drugs, healthcare providers can tailor treatments to specific genetic profiles, enhancing therapeutic outcomes.

Recent studies have highlighted the role of isotopically labeled compounds in studying enzyme kinetics and binding interactions. For instance, researchers have utilized (±)-Atropine-d3 (N-methyl-d3) to investigate how atropine derivatives interact with muscarinic receptors. These studies have not only deepened our understanding of receptor mechanisms but also paved the way for new therapeutic strategies targeting neurological disorders such as Alzheimer's disease and myasthenia gravis.

The versatility of (±)-Atropine-d3 (N-methyl-d3) is further demonstrated by its use in synthetic chemistry. Its stable deuterium atoms serve as handles for synthetic modifications, allowing chemists to design complex molecules with enhanced isotopic enrichment. This capability is particularly valuable in multi-step synthesis where maintaining high levels of purity is essential. The compound's compatibility with various reaction conditions makes it a preferred choice for researchers aiming to push the boundaries of synthetic methodologies.

In conclusion, (±)-Atropine-d3 (N-methyl-d3) stands as a cornerstone in modern chemical research due to its unique properties and broad applicability. The combination of its precise CAS number 1276197-36-4 and isotopic labeling offers unparalleled opportunities for advancing our understanding of drug metabolism, receptor interactions, and synthetic chemistry. As research continues to evolve, compounds like this will undoubtedly play a central role in shaping the future of pharmaceutical science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)